Genetic Technologies updates patent program, grants license

|By:, SA News Editor

Genetic Technologies (GENE) grants a license to Bio-Reference Labs (BRLI) — terms are confidential "as is typical in such cases."

GENE is also "pleased to report" that it is "actively pursuing its patent assertion program and there are now "several significant cases" pending in Delaware "including cases against PFE, BMY, and Merial." (PR)

GENE +13% premarket